Evidence map›Paper›PMID 41907276›Full record

ArticleFrontiers in medicine2026

Diabetic retinopathy severity detection using an improved Whale optimization algorithm and convolutional Kolmogorov-Arnold network.

Ashit Kumar Dutta, Nasser Ali Aljarallah, Abdul Rahaman Wahab Sait

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ashit Kumar DuttaDepartment of Computer Science and Information Systems, College of Applied Sciences, AlMaarefa University, Riyadh, Saudi Arabia.
Nasser Ali AljarallahDepartment of Computer Science and Information Systems, College of Applied Sciences, AlMaarefa University, Riyadh, Saudi Arabia.
Abdul Rahaman Wahab SaitKing Salman Center for Disability Research, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Diabetic retinopathy (DR) is an inflammatory condition affecting the retina caused by elevated and unregulated blood glucose levels. On a global scale, it is a contributing factor to vision impairment. Several deep learning (DL) methods use retinal images to identify DR severity. However, a significant improvement is required to assist medical professionals in recognizing DR in its early phases. Methods: Thus, the author introduced a method based on the DL technique to determine the DR severity grades using retinal images. A ShuffleNet V2 model with vision transformers' (ViT) attention mechanism was used to extract the features. An improved Whale optimization method (IWO) was used to fine-tune the feature extraction model. We employed a convolutional Kolmogorov-Arnold Network to categorize the DR severity using the extracted features. The EyePACS dataset was utilized to train the proposed DR severity grading model using a five-fold cross-validation strategy. We generalized the model on the Messidor-2 dataset. Results: The findings revealed an average accuracy of 93.84% on the MESSIDOR-2 dataset, demonstrating a substantial improvement in detecting DR using the fundus images. Discussion: Furthermore, the model demands minimal processing resources to generate the outcomes, leading to the deployment of the proposed DR severity detection model in healthcare facilities with limited computational resources.

Indexed as

diabetic retinopathyfundus imageshyperparameter optimizationimproved Whale optimizationKolmogorov-Arnold networkpre-trained modelsShuffleNet V2transfer learning

Identifiers

PMID41907276
PMCPMC13022980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.